الاستروجين والأمراض التنكسية العصبية (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "الاستروجين والأمراض التنكسية العصبية" in Arabic language version.

refsWebsite

Global rank Arabic rank

15nih.gov

4^th place

6^th place

13doi.org

2^nd place

5^th place

6semanticscholar.org

11^th place

86^th place

1harvard.edu

18^th place

33^rd place

1web.archive.org

1^st place

1escholarship.org

1,523^rd place

1,751^st place

doi.org

Fratiglioni، L؛ Grut M؛ Forsell Y؛ وآخرون (ديسمبر 1991). "Prevalence of Alzheimer's disease and other dementias in an elderly urban population". Neurology. ج. 41 ع. 12: 1886–92. DOI:10.1212/wnl.41.12.1886. PMID:1745343. S2CID:43648760.
Leung، Kin-Chuen؛ Gudmundur Johannsson؛ Gary M. Leong؛ Ken K. Y. Ho (أكتوبر 2004). "Estrogen Regulation of Growth Hormone Action". Endocrine Reviews. ج. 25 ع. 5: 693–721. DOI:10.1210/er.2003-0035. PMID:15466938.
Pettersson، Katarina؛ Jan-Åke Gustafsson (مارس 2001). "Role of Estrogen Receptor Beta in Estrogen Action". Annual Review of Physiology. ج. 63: 165–192. DOI:10.1146/annurev.physiol.63.1.165. PMID:11181953.
Sharma، Hari S.؛ Muresanu, Dafin F.؛ Sharma, Aruna (أكتوبر 2013). "Novel therapeutic strategies using nanodrug delivery, stem cells and combination therapy for CNS trauma and neurodegenerative disorders". Expert Review of Neurotherapeutics. ج. 13 ع. 10: 1085–1088. DOI:10.1586/14737175.2013.836297. PMID:24089700. S2CID:24356630.
Gandy، S. (يوليو 2003). "Estrogen and neurodegeneration". Neurochemistry Research. ج. 28 ع. 7: 1003–8. DOI:10.1023/A:1023246921127. PMID:12737524. S2CID:12116802.
Zhang، She-Qing؛ وآخرون (أغسطس 2013). "Octyl Gallate Markedly Promotes Anti-amyloidogenic Processing of APP through Estrogen Receptor-Mediated ADAM10 Activation". PLOS ONE. ج. 8 ع. 8: e71913. Bibcode:2013PLoSO...871913Z. DOI:10.1371/journal.pone.0071913. PMC:3744472. PMID:23977176.
JAFFE، AB؛ وآخرون (1994). "Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein". Journal of Biological Chemistry. ج. 269 ع. 18: 13065–13068. DOI:10.1016/S0021-9258(17)36796-0. PMID:8175728.
Kompoliti، K (مايو 2003). "Estrogen and Parkinson's disease". Frontiers in Bioscience. ج. 8 ع. 6: 391–400. DOI:10.2741/1070. PMID:12700049.
Pullman، R. Saunders؛ وآخرون (أبريل 1999). "The effect of estrogen replacement on early Parkinson's disease". Neurology. ج. 52 ع. 7: 1417–21. DOI:10.1212/wnl.52.7.1417. PMID:10227628. S2CID:24749803.
Rudnicki، SA (أكتوبر 1999). "Estrogen and Amyotrophic lateral sclerosis". Journal of the Neurological Sciences. ج. 169 ع. 1–2: 126–7. DOI:10.1016/s0022-510x(99)00234-8. PMID:10540020. S2CID:29442303.
Groenerveld، G.J.؛ وآخرون (سبتمبر 2004). "Ovariectomy and 17β-estradiol modulate disease progression of a mouse model of ALS". Brain Research. ج. 1021 ع. 1: 128–131. DOI:10.1016/j.brainres.2004.06.024. PMID:15328040. S2CID:38207502.
Writing Group for the Women's Health Initiative Investigators (2002). "Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial" (PDF). JAMA. ج. 288 ع. 3: 321–333. DOI:10.1001/jama.288.3.321. PMID:12117397. مؤرشف من الأصل (PDF) في 2023-10-15.
Chlebowski، RT؛ Kuller LH؛ Prentice RL؛ Stefanick ML؛ Manson JE؛ Gass M؛ وآخرون (2009). "Breast cancer after use of estrogen plus progestin in postmenopausal women". NEJM. ج. 360 ع. 6: 573–87. DOI:10.1056/NEJMoa0807684. PMC:3963492. PMID:19196674.

escholarship.org

Writing Group for the Women's Health Initiative Investigators (2002). "Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial" (PDF). JAMA. ج. 288 ع. 3: 321–333. DOI:10.1001/jama.288.3.321. PMID:12117397. مؤرشف من الأصل (PDF) في 2023-10-15.

harvard.edu

ui.adsabs.harvard.edu

Zhang، She-Qing؛ وآخرون (أغسطس 2013). "Octyl Gallate Markedly Promotes Anti-amyloidogenic Processing of APP through Estrogen Receptor-Mediated ADAM10 Activation". PLOS ONE. ج. 8 ع. 8: e71913. Bibcode:2013PLoSO...871913Z. DOI:10.1371/journal.pone.0071913. PMC:3744472. PMID:23977176.

nih.gov

pubmed.ncbi.nlm.nih.gov

Fratiglioni، L؛ Grut M؛ Forsell Y؛ وآخرون (ديسمبر 1991). "Prevalence of Alzheimer's disease and other dementias in an elderly urban population". Neurology. ج. 41 ع. 12: 1886–92. DOI:10.1212/wnl.41.12.1886. PMID:1745343. S2CID:43648760.
Leung، Kin-Chuen؛ Gudmundur Johannsson؛ Gary M. Leong؛ Ken K. Y. Ho (أكتوبر 2004). "Estrogen Regulation of Growth Hormone Action". Endocrine Reviews. ج. 25 ع. 5: 693–721. DOI:10.1210/er.2003-0035. PMID:15466938.
Pettersson، Katarina؛ Jan-Åke Gustafsson (مارس 2001). "Role of Estrogen Receptor Beta in Estrogen Action". Annual Review of Physiology. ج. 63: 165–192. DOI:10.1146/annurev.physiol.63.1.165. PMID:11181953.
Sharma، Hari S.؛ Muresanu, Dafin F.؛ Sharma, Aruna (أكتوبر 2013). "Novel therapeutic strategies using nanodrug delivery, stem cells and combination therapy for CNS trauma and neurodegenerative disorders". Expert Review of Neurotherapeutics. ج. 13 ع. 10: 1085–1088. DOI:10.1586/14737175.2013.836297. PMID:24089700. S2CID:24356630.
Gandy، S. (يوليو 2003). "Estrogen and neurodegeneration". Neurochemistry Research. ج. 28 ع. 7: 1003–8. DOI:10.1023/A:1023246921127. PMID:12737524. S2CID:12116802.
Zhang، She-Qing؛ وآخرون (أغسطس 2013). "Octyl Gallate Markedly Promotes Anti-amyloidogenic Processing of APP through Estrogen Receptor-Mediated ADAM10 Activation". PLOS ONE. ج. 8 ع. 8: e71913. Bibcode:2013PLoSO...871913Z. DOI:10.1371/journal.pone.0071913. PMC:3744472. PMID:23977176.
JAFFE، AB؛ وآخرون (1994). "Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein". Journal of Biological Chemistry. ج. 269 ع. 18: 13065–13068. DOI:10.1016/S0021-9258(17)36796-0. PMID:8175728.
Kompoliti، K (مايو 2003). "Estrogen and Parkinson's disease". Frontiers in Bioscience. ج. 8 ع. 6: 391–400. DOI:10.2741/1070. PMID:12700049.
Pullman، R. Saunders؛ وآخرون (أبريل 1999). "The effect of estrogen replacement on early Parkinson's disease". Neurology. ج. 52 ع. 7: 1417–21. DOI:10.1212/wnl.52.7.1417. PMID:10227628. S2CID:24749803.
Rudnicki، SA (أكتوبر 1999). "Estrogen and Amyotrophic lateral sclerosis". Journal of the Neurological Sciences. ج. 169 ع. 1–2: 126–7. DOI:10.1016/s0022-510x(99)00234-8. PMID:10540020. S2CID:29442303.
Groenerveld، G.J.؛ وآخرون (سبتمبر 2004). "Ovariectomy and 17β-estradiol modulate disease progression of a mouse model of ALS". Brain Research. ج. 1021 ع. 1: 128–131. DOI:10.1016/j.brainres.2004.06.024. PMID:15328040. S2CID:38207502.
Writing Group for the Women's Health Initiative Investigators (2002). "Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial" (PDF). JAMA. ج. 288 ع. 3: 321–333. DOI:10.1001/jama.288.3.321. PMID:12117397. مؤرشف من الأصل (PDF) في 2023-10-15.
Chlebowski، RT؛ Kuller LH؛ Prentice RL؛ Stefanick ML؛ Manson JE؛ Gass M؛ وآخرون (2009). "Breast cancer after use of estrogen plus progestin in postmenopausal women". NEJM. ج. 360 ع. 6: 573–87. DOI:10.1056/NEJMoa0807684. PMC:3963492. PMID:19196674.

ncbi.nlm.nih.gov

Zhang، She-Qing؛ وآخرون (أغسطس 2013). "Octyl Gallate Markedly Promotes Anti-amyloidogenic Processing of APP through Estrogen Receptor-Mediated ADAM10 Activation". PLOS ONE. ج. 8 ع. 8: e71913. Bibcode:2013PLoSO...871913Z. DOI:10.1371/journal.pone.0071913. PMC:3744472. PMID:23977176.
Chlebowski، RT؛ Kuller LH؛ Prentice RL؛ Stefanick ML؛ Manson JE؛ Gass M؛ وآخرون (2009). "Breast cancer after use of estrogen plus progestin in postmenopausal women". NEJM. ج. 360 ع. 6: 573–87. DOI:10.1056/NEJMoa0807684. PMC:3963492. PMID:19196674.

semanticscholar.org

api.semanticscholar.org

Fratiglioni، L؛ Grut M؛ Forsell Y؛ وآخرون (ديسمبر 1991). "Prevalence of Alzheimer's disease and other dementias in an elderly urban population". Neurology. ج. 41 ع. 12: 1886–92. DOI:10.1212/wnl.41.12.1886. PMID:1745343. S2CID:43648760.
Sharma، Hari S.؛ Muresanu, Dafin F.؛ Sharma, Aruna (أكتوبر 2013). "Novel therapeutic strategies using nanodrug delivery, stem cells and combination therapy for CNS trauma and neurodegenerative disorders". Expert Review of Neurotherapeutics. ج. 13 ع. 10: 1085–1088. DOI:10.1586/14737175.2013.836297. PMID:24089700. S2CID:24356630.
Gandy، S. (يوليو 2003). "Estrogen and neurodegeneration". Neurochemistry Research. ج. 28 ع. 7: 1003–8. DOI:10.1023/A:1023246921127. PMID:12737524. S2CID:12116802.
Pullman، R. Saunders؛ وآخرون (أبريل 1999). "The effect of estrogen replacement on early Parkinson's disease". Neurology. ج. 52 ع. 7: 1417–21. DOI:10.1212/wnl.52.7.1417. PMID:10227628. S2CID:24749803.
Rudnicki، SA (أكتوبر 1999). "Estrogen and Amyotrophic lateral sclerosis". Journal of the Neurological Sciences. ج. 169 ع. 1–2: 126–7. DOI:10.1016/s0022-510x(99)00234-8. PMID:10540020. S2CID:29442303.
Groenerveld، G.J.؛ وآخرون (سبتمبر 2004). "Ovariectomy and 17β-estradiol modulate disease progression of a mouse model of ALS". Brain Research. ج. 1021 ع. 1: 128–131. DOI:10.1016/j.brainres.2004.06.024. PMID:15328040. S2CID:38207502.

web.archive.org

Writing Group for the Women's Health Initiative Investigators (2002). "Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial" (PDF). JAMA. ج. 288 ع. 3: 321–333. DOI:10.1001/jama.288.3.321. PMID:12117397. مؤرشف من الأصل (PDF) في 2023-10-15.